3,4-diarylpyrazole derivatives of formula (I) as defined in the specification,and pharmaceutically acceptable saltsthereof, process for their preparation and pharmaceutical compositionscomprising them are disclosed; the compounds of the inventionmay be useful, in therapy, in the treatment of diseases associated with adisregulated protein kinase activity, like cancer.